Francisco Veas Selected Research

Francisco Veas Research Topics

4	COVID-19 12/2022 - 10/2021
4	Infections 05/2011 - 01/2003
3	Inflammation (Inflammations) 01/2018 - 12/2008
2	Persistent Infection 12/2012 - 05/2008
2	HIV Infections (HIV Infection) 10/2007 - 01/2007
1	Bacteremia 01/2023
1	Shock 01/2023
1	Coinfection 10/2021
1	Pneumonia (Pneumonitis) 10/2021
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Yellow Fever 04/2021
1	Multiple Sclerosis 12/2012
1	Hantavirus Infections 05/2009
1	Schizophrenia (Dementia Praecox) 12/2008
1	Fever (Fevers) 11/2006

3	C-Reactive ProteinIBA 01/2023 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2008
2	AntibodiesIBA 12/2022 - 04/2021
2	VaccinesIBA 01/2022 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 12/2012 - 12/2008
2	AntigensIBA 12/2012 - 12/2008
1	Ferritins (Ferritin)IBA 01/2023
1	ProcalcitoninIBA 01/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2023
1	Monoclonal AntibodiesIBA 12/2022
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 12/2022
1	Peptides (Polypeptides)IBA 12/2022
1	Oxygen (Dioxygen)IBA 10/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2021
1	Immunoglobulin M (IgM)IBA 04/2021
1	Immunoglobulin G (IgG)IBA 04/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	ElementsIBA 12/2012
1	Interleukin-10 (Interleukin 10)IBA 05/2011
1	CytokinesIBA 05/2011
1	Antiviral Agents (Antivirals)IBA 05/2009
1	AerosolsIBA 05/2009
1	env Gene ProductsIBA 12/2008
1	Nucleic AcidsIBA 05/2008
1	Apolipoprotein C-IIIIBA 05/2008
1	ChemokinesIBA 10/2007
1	Immunoglobulin A (IgA)IBA 10/2007
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2007
1	Interleukin-22 (IL-22)IBA 01/2007
1	Metalloproteases (Metalloproteinases)IBA 11/2006
1	recombinant soluble CD4IBA 01/2003